RxSight, Inc. (RXST) Stock

RxSight, Inc. (RXST) is a Healthcare stock trading at $4.71 (as of 2026-06-18), with a market capitalization of $220.64M and a trailing P/E of -4.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

RxSight, Inc. develops, manufactures, and sells light-adjustable intraocular lenses used during cataract surgery. Its RxSight system includes a light delivery device that provides office-based UV light in a programmed pattern to adjust the lenses after implantation, serving cataract physicians in the U.S. and internationally.

Valuation — source: SEC EDGAR (first-party)
Price	$4.71
Market Cap	$220.64M
P/E Ratio	-4.1
EV / EBITDA	-3.3
Price / Book	0.71
Price / Sales	1.49
DCF Value (model)	$-7.48
DCF Upside vs Price	-259.0%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$134.48M
Net Margin	-29.0%
Return on Equity	-17.4%
Current Ratio	10.20
Revenue Growth (YoY)	-3.9%
EPS Growth (YoY)	33.8%
FCF Growth (YoY)	-13.6%

Financial Health — source: SEC EDGAR
Altman Z-Score	1.18 (distress)

Valuation vs Sector & Industry
Stock P/E	-4.1
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-119.4%
vs Industry	-112.8%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	VANGUARD GROUP INC ($23.23M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Ronald Kurtz
Employees	498
Country	US
IPO Date	2021-07-30

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.